Edwin K. Jackson, PhD

Edwin Jackson - Research Series Speaker

Dr. Jackson received his pharmacy degree at the University of Texas at Austin in 1976 and his PhD in pharmacology at the University of Texas Southwestern Medical Center in Dallas in 1979.  After a post-doctoral fellowship in clinical pharmacology at Vanderbilt University, Dr. Jackson joined the faculty in the Department of Pharmacology at Vanderbilt in 1981, and was promoted to Associate Professor in 1985 and Professor in 1989.  In 1991, Dr. Jackson relocated to the University of Pittsburgh where he is currently Professor of Pharmacology and Chemical Biology.  Dr. Jackson has published 351 peer-reviewed articles, 84 book chapters/reviews/commentaries and 349 meeting abstracts, and has 16 issued patents. His publications have been cited approximately 19,000 times (h-index, 71).  He is currently PI on 4 R01s, directs a core in the Pittsburgh P30 O’Brien Kidney Center and is a co-investigator on 2 additional R01s and a U01.  He has served on grant review committees for the NIH, American Heart Association, and Veterans Administration.  Dr. Jackson’s primary research is in the field of cardiovascular/renal pharmacology with an emphasis on mechanisms of and treatments for hypertension and vascular and kidney diseases.  However, his work in purine pharmacology, initially related to his research in the cardiovascular system, has led to the expansion of his research endeavors into traumatic brain injury, immunology, and cancer.


Back to Previous Page